1 authorised product containing Recombinant varicella zoster virus surface glycoprotein e, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Shingrix powder and suspension for suspension for injection. Herpes zoster vaccine (recombinant, adjuvanted). EU/1/18/1272/001-002 |
Recombinant varicella zoster virus surface glycoprotein e | GlaxoSmithKline Biologicals S.A. | โ |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (โAuthorised or Transfer Pending Productsโ), licensed CC BY 4.0, refreshed daily. Regulatory information only โ not medical advice.